跳至主要内容
临床试验/KCT0003040
KCT0003040招募中未知

Study for evaluation of cholesterol lowering effect, dose and safety of Bifidobacterium breve IDCC 4401

Ildong pharmaceutical0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) who agree to participate and consent
  • 2) age of 20 or greater
  • 3) 100mg/dl <= Low density lipoprotein cholesterol <150 mg/dl

排除标准

  • 1) use of lipid modifying drug within one month 2) cardiovascular disease, uncontrolled hypertension (systolic blood pressure >=160mmHg or diastolic blood pressure >=100mmHg) , uncontrolled diabetes mellitus (fasting blood glucose >=180mg/dL)AST or ALT>= 3 x upper limit of reference value, serum creatinine >= 1.4 mg/dL, Gastrointestinal disease, autoimmune diesase, endocrine disease (hyper or hypothyroidism), malignancy 3) triglyceride >= 500 mg/dL 4) regular use of functional food altering lipid profiles within 1 month (phytosterol, omega-3, dietary fiber etc) 5) alcohol dependency 6) who participate other clinical trial within one month 7) hypersensitivity to probiotics 8) pregnancy or lactating women 9) person who is inappropriate to participate study determined by investigator

研究者

相似试验